News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,697 Results
Type
Article (49882)
Company Profile (278)
Press Release (687537)
Multimedia
Podcasts (64)
Webinars (12)
Section
Business (212370)
Career Advice (2104)
Deals (36547)
Drug Delivery (105)
Drug Development (83655)
Employer Resources (173)
FDA (16994)
Job Trends (15730)
News (359425)
Policy (34716)
Tag
Academia (2782)
Accelerated approval (5)
Adcomms (23)
Allergies (89)
Alliances (51636)
ALS (98)
Alzheimer's disease (1443)
Antibody-drug conjugate (ADC) (137)
Approvals (16990)
Artificial intelligence (283)
Autoimmune disease (23)
Automation (16)
Bankruptcy (373)
Best Places to Work (12099)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (191)
Bladder cancer (80)
Brain cancer (29)
Breast cancer (301)
Cancer (2364)
Cardiovascular disease (191)
Career advice (1766)
Career pathing (31)
CAR-T (156)
Cell therapy (440)
Cervical cancer (22)
Clinical research (68007)
Collaboration (881)
Company closure (2)
Compensation (560)
Complete response letters (21)
COVID-19 (2720)
CRISPR (43)
C-suite (262)
Cystic fibrosis (102)
Data (2326)
Decentralized trials (2)
Denatured (29)
Depression (51)
Diabetes (282)
Diagnostics (6593)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (109)
Drug shortages (28)
Duchenne muscular dystrophy (98)
Earnings (89134)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (117668)
Executive appointments (754)
FDA (18402)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (786)
Gene editing (114)
Generative AI (25)
Gene therapy (318)
GLP-1 (770)
Government (4701)
Grass and pollen (4)
Guidances (150)
Healthcare (19908)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (125)
Indications (30)
Infectious disease (2871)
Inflammatory bowel disease (148)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (97)
Interviews (321)
IPO (16892)
IRA (41)
Job creations (4049)
Job search strategy (1504)
Kidney cancer (10)
Labor market (42)
Layoffs (492)
Leadership (19)
Legal (8469)
Liver cancer (79)
Lung cancer (333)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (330)
MASH (76)
Medical device (14391)
Medtech (14396)
Mergers & acquisitions (20228)
Metabolic disorders (739)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (102)
Neuropsychiatric disorders (31)
Neuroscience (2018)
NextGen: Class of 2025 (6913)
Non-profit (4740)
Now hiring (40)
Obesity (394)
Opinion (219)
Ovarian cancer (81)
Pain (96)
Pancreatic cancer (89)
Parkinson's disease (155)
Partnered (21)
Patents (244)
Patient recruitment (117)
Peanut (48)
People (60209)
Pharmaceutical (68)
Pharmacy benefit managers (20)
Phase I (21157)
Phase II (29889)
Phase III (22322)
Pipeline (1356)
Policy (149)
Postmarket research (2741)
Preclinical (9041)
Press Release (67)
Prostate cancer (110)
Psychedelics (32)
Radiopharmaceuticals (257)
Rare diseases (395)
Real estate (6306)
Recruiting (65)
Regulatory (23754)
Reports (47)
Research institute (2485)
Resumes & cover letters (359)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (77)
Series A (132)
Series B (90)
Service/supplier (13)
Sickle cell disease (54)
Special edition (15)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3834)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (47)
The Weekly (33)
Vaccines (739)
Venture capitalists (43)
Weight loss (264)
Women's health (38)
Worklife (16)
Date
Today (179)
Last 7 days (944)
Last 30 days (3102)
Last 365 days (33331)
2025 (11921)
2024 (36116)
2023 (41149)
2022 (52391)
2021 (57111)
2020 (55925)
2019 (48815)
2018 (36956)
2017 (33758)
2016 (33579)
2015 (39624)
2014 (33332)
2013 (28567)
2012 (30860)
2011 (31561)
2010 (29936)
Location
Africa (795)
Alabama (55)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (41058)
Australia (6765)
California (6432)
Canada (2070)
China (552)
Colorado (283)
Connecticut (295)
Delaware (160)
Europe (89072)
Florida (954)
Georgia (220)
Idaho (61)
Illinois (587)
India (26)
Indiana (325)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (959)
Massachusetts (4828)
Michigan (231)
Minnesota (416)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (69)
New Hampshire (68)
New Jersey (1813)
New Mexico (29)
New York (1816)
North Carolina (1059)
North Dakota (8)
Northern California (2821)
Ohio (210)
Oklahoma (14)
Oregon (35)
Pennsylvania (1428)
Puerto Rico (13)
Rhode Island (35)
South America (1186)
South Carolina (26)
South Dakota (1)
Southern California (2421)
Tennessee (107)
Texas (959)
United States (24385)
Utah (193)
Virginia (156)
Washington D.C. (68)
Washington State (582)
West Virginia (3)
Wisconsin (58)
737,697 Results for "benchmark medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
Belite Bio, Inc. today announced that the executive management team will participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference being held virtually on May 21 and 22, 2024.
May 14, 2024
·
1 min read
Press Releases
BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development
April 29, 2025
·
6 min read
Genetown
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.
May 16, 2024
·
1 min read
Press Releases
Biofrontera Inc. to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
December 3, 2024
·
4 min read
BioMidwest
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
Assertio Holdings, Inc. announced that Ajay Patel, Chief Financial Officer, will host investor meetings as part of the Benchmark & Company Healthcare House Call Virtual Conference, taking place May 21-22, 2024.
May 17, 2024
·
2 min read
Press Releases
Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
December 9, 2024
·
1 min read
Pharm Country
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference
STRATA Skin Sciences, Inc. announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, and Christopher Lesovitz, Chief Financial Officer, will participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference being held on May 21 – 22, 2024.
May 13, 2024
·
3 min read
Biotech Beach
Modular Medical to Attend the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
Modular Medical, Inc. today announced it will be presenting at the Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference to be held Thursday, December 7, 2023 at the New York Athletic Club in New York City.
November 14, 2023
·
2 min read
Press Releases
STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
December 6, 2024
·
2 min read
Drug Development
Worldwide Clinical Trials Recognized as Highest Rated Phase I Provider for Overall User Preference in 2024 Industry Standard Research Phase I Benchmarking Report
Worldwide Clinical Trials (Worldwide), a global full-service contract research organization (CRO), proudly announces results of the 2024 Industry Standard Research (ISR) Phase I CRO Benchmarking Report.
June 25, 2024
·
4 min read
1 of 73,770
Next
